Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hp strain typing and host susceptibility gene-based gastric cancer early warning and intervention study
ChiCTR1900023366Phase 4Not yet recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of furazolidone, tetracycline, amoxicillin, clarithromycin and bismuth subsalicylate in Helicobacter pylori infection (3 arms), sponsored by Massachusetts General Hospital. Primary endpoints: Gastrin-17, Pepsinogen I/II and 2 more. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
furazolidonetetracyclineamoxicillinclarithromycinbismuth subsalicylate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR1900023366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023366.